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Abstract  
 
Quality of life (QOL) in children with acute lymphoblastic leukaemia (ALL) is now 
considered an important outcome measure of treatment for this disease. The aim of this paper 
is to systematically review studies on QOL in children during treatment for ALL with 
consideration to methodological details and quality of studies, empirical findings on QOL as 
reported by children and parents, and whether children and parents differ in their reports on 
QOL. Searches were conducted in biomedical, psychological and behavioural science 
databases. Six papers met inclusion criteria for review: 4 cross-sectional studies and 2 
qualitative studies. There was little consistency in how QOL was measured or qualitatively 
assessed across studies. The quality of most studies was limited by small sample sizes and 
cross sectional designs. Children’s reports on QOL were represented in 3 studies and 
discrepancies were found between children’s and parents’ accounts of QOL. There is a need 
for ongoing research on QOL in children with ALL using longitudinal designs, large sample 
sizes, and child reports on QOL. There is a need for theoretical development of the concept of 
QOL through concept analysis, grounded theory research and empirical validation of 
developing theory of QOL. Theoretical development of the concept of QOL will contribute to 
greater clarification of what is meant by QOL than currently exists which in turn has the 
potential to advance the methodology of measuring this concept in children.   
 
Introduction 
 
Acute lymphoblastic leukaemia (ALL) accounts for over 75% of childhood 
leukaemias and is the most common childhood cancer (Coebergh et al., 2006). It is a 
complex malignant disease that affects haematopoietic cells of the bone marrow and 
is typified by the malignant proliferation of lymphoblasts that affect the normal 
process of maturation and differentiation of cells in the bone marrow, resulting in the 
replacement of normal bone marrow tissue with cancerous cells (Plasschaert et al., 
2004).  
The highest incidence of ALL occurs in the first five years of life at 
approximately 5.7 per 100 000 persons per annum (Plasschaert et al., 2004). In the 
past, a diagnosis of ALL meant a certain fatality. However, over the past five decades, 
survival rates for childhood leukaemia have increased. European data on patterns of 
survival between 1988 and 1997 have estimated 5 year survival rates at 80% for 
children diagnosed between 1-4 years of age, 75% for children diagnosed between 5-9 
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years of age, 62% for children diagnosed between 10-14 years. Survival rates in 
infants diagnosed with leukemia was notably lower at 44% (Coebergh et al., 2006).   
Aggressive treatment protocols over 2 to 3 years involving combination 
chemotherapy have greatly influenced improvements in survival of children with 
ALL. Treatment typically involves a sequence of stages: induction of remission, 
consolidation, and maintenance therapy. Prophylactic therapy is used to prevent 
central nervous system disease, involving intrathecal chemotherapy and possibly 
cranial radiation for children with high risk disease. In the case of disease relapse, 
children are inducted into remission again and bone marrow transplantation is offered 
(Cholby-Graham and Chordas, 2003; Schmiegelow and Gustafsson, 2005).       
Although the outlook for survival is now positive for children with ALL, 
facing a life threatening condition can be intensely distressing for children and their 
parents. Family life as previously understood becomes disrupted and the child, parents 
and other family members are confronted with a lengthy treatment regime and 
possible side effects. In the initial and intermediary treatment phase, children can 
experience unpleasant physical side effects such as nausea and vomiting, mucositis, 
fatigue, bleeding and infection (Viele, 2003). Behavioural and emotional problems in 
children may arise (Eiser et al., 2005). The toxic nature of treatment can have long 
term adverse effects on children including impaired intellectual function, 
neuroendocrine abnormalities, cardiotoxicity, impaired reproductive capacity and 
secondary malignancy (Bhatia, 2003).  
Recognition of the adverse effects of treatment for ALL has resulted in a 
growth of interest in quality of life (QOL) assessment of children. In health care, the 
concept of QOL, often used interchangeably with the term ‘health related QOL’ is 
generally understood as a multidimensional construct concerning an individual’s 
perception of the impact of illness and treatment on his/her health, wellbeing or 
functioning in relation to physical, psychological, and social aspects of life (Eiser and 
Morse, 2001; Varni et al., 2005).  QOL is now considered an important outcome 
measure for children with cancers not just in the long term but also during courses of 
treatment. The focus on ALL in this paper is important because, as already noted, 
ALL accounts for most childhood cancers. 
A systematic review by Pickard et al. (2004) provided a comprehensive 
account of research on health related quality of life (referred to as QOL hereafter) 
specific to children with ALL spanning over 25 years from 1975 to 2001. A principal 
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aim of this review was to summarize studies that applied health related QOL 
measures to ALL. The reviewers noted that researchers have an increasing number of 
instruments available to them for measuring QOL that are either generic or disease 
specific. Most of the 29 studies reviewed were found to have used generic measures 
in children on or off treatment. Generic measures are appropriate for survivors, and 
may provide useful information for comparing QOL in children on treatment with 
healthy populations. However, disease specific measures are needed for children on 
treatment and these should be sensitive to changes in QOL during the course of a 
particular disease and its treatment. Pickard et al. highlighted a need for ongoing 
assessment of psychometric properties concerning validity and reliability of existing 
and newly developed QOL measures in children with ALL as a priority in future 
research.    
A limitation of previous studies, identified by Pickard et al. (2004), was that 
children’s own views on QOL were generally underrepresented. The reviewers 
cautioned against reliance on proxy accounts of parents when measuring children’s 
QOL because information gleaned from children’s reports may not be available in 
parents’ reports. Pickard et al. concluded that children can respond on their own 
behalf and that they can provide reliable accounts of their QOL by the ages of 7 to 8 
years.  
Since Pickard et al.’s review, researchers have continued to measure QOL in 
children with ALL. However, uncertainty remains about how this research has 
advanced methodologically. To extend knowledge in this area, we conducted a 
systematic review of recent studies on QOL in children receiving treatment for ALL. In 
addition to examining methodological aspects of studies similar to Pickard et al., we 
examined empirical data. A synthesis of empirical data is important to identifying 
aspects of children’s QOL that may be more or less affected during various stages of 
treatment, which in turn may be useful to practitioners when addressing QOL within 
the overall care and management of children with ALL.  
In this paper, we aim to report on a systematic review of studies on QOL in 
children with ALL.  We specifically focused on QOL of children on treatment for 
ALL since little is known about children’s QOL during treatment stages of their 
illness trajectories compared to survival stage. The objectives for this review were to: 
(i) describe the methodological approaches and quality of studies undertaken on 
quality of life in children on treatment for ALL; (ii) summarise research findings on 
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children’s quality of life as reported by children and/or their parents; (iii) determine 
whether children and parents differ in their reports on children’s quality of life during 
treatment for ALL. 
 
Criteria for selecting studies  
 
Inclusion and exclusion criteria were specified prior to commencing the search 
strategy. These criteria related to types of studies, types of participants, and types of 
outcomes.  
 
Types of studies 
 
Published studies that examined QOL in children receiving treatment for ALL were 
considered for inclusion provided that they addressed one or more of the objectives of 
this review. Both quantitative and qualitative studies were considered, including all 
research designs. A minimum quality threshold for the selection of primary studies 
was not applied. Studies on instrument development and measurement were included 
if empirical data on QOL could be extracted. English language studies only were 
considered. This review was restricted to studies published between 30th April 2001 
and 30th June 2007 since a previous review on QOL in children with ALL examined 
studies up to end of April 2001 (Pickard et al., 2004). Studies that did not address at 
least one of the objectives of the review were excluded. While many studies have 
investigated QOL across a range of childhood cancers, these were excluded if data 
specific to children undergoing treatment for ALL were not provided.  
 
Types of participants 
 
Children on treatment for ALL were selected. Children up to 12 years only were 
included since most children receiving treatment for ALL can be expected to fall into 
this age group (Plasschaert et al., 2004). Parents of children on treatment for ALL 
were also included because of ongoing issues being raised about ‘proxy raters’ of 
QOL measures in children (Eiser and Jenney, 2007).    
 
Types of outcome measures  
 
The outcome measure central to this review was QOL in children during treatment for 
ALL.  We were interested in extracting data on all aspects of QOL reported in studies 
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including widely recognised QOL dimensions (physical, psychological, social) or any 
other dimension described. Studies with outcome data gleaned from generic or disease 
specific measures of QOL were considered eligible for inclusion. Studies that 
examined QOL in the context of specific drug therapies or procedures (e.g. central 
line insertion) were excluded.  
Search strategy for identification of studies 
 
Databases searched for potentially eligible studies for this review included 
MEDLINE, EMBASE, CINAHL, BIOSIS previews, Faculty of 1000 medicine, 
Psychology and Behavioral Sciences Collection, PubMed, Social Index and 
CancerLit. MeSH and subject terms appropriate for each database were applied. The 
term ‘quality of life’ was used as a constant search term in all databases and was 
combined with various terms specific to the disease (acute lymphoblastic 
leukaemia/acute lymphocytic leukaemia/ leukaemia/neoplasm). These various 
combinations were further combined with terms specific to the patient group being 
reviewed (child/children/pediatric/ paediatric). Journals in the fields of paediatric and 
general oncology were electronically searched, as well as some general paediatric 
journals noted to publish QOL papers.  Oncology journals searched were:  Cancer; 
Journal of Cancer Care; European Journal of Oncology Nursing; Hematology; 
Oncology; Pediatric Blood Cancer. General paediatric journals searched were:  Acta 
Paediatrica; Journal of Pediatrics, and European Journal of Pediatrics. Journals 
searched specific to QOL were also electronically searched. These were: Quality of 
Life Research, and Health and Quality of Life Outcomes. A search was done by 
combining the term ‘quality of life’ with two individual authors (Eiser, C. and Varni, 
J) on noting from our initial database searches that both authors had multiple 
publications on QOL in children with cancer. Reference lists of all full papers 
retrieved from databases, electronic journals and individual author searches yielded 
additional papers. We limited our search strategy to between May 1st 2001 and June 
30th 2007.  We did not search for unpublished studies.  The restriction of inclusion 
criteria to papers in the English language and to published studies is a limitation of 
this review.  
 
Methods of review 
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A total of 84 records were identified that seemed potentially relevant to this review. 
The abstract of each record was independently scanned by two reviewers (AOR, ES). 
Agreement was reached to read 23 papers in full to further examine their relevance 
based on inclusion and exclusion criteria. Two reviewers (AOR, ES) independently 
read the papers in full and reached mutual agreement that 4 papers met the inclusion 
criteria and that 16 papers were to be excluded. There was disagreement on 3 papers. 
These were then read by MH, and following discussion between all three reviewers, 
consensus was reached that a further 2 papers be included yielding a total of 6 papers 
for review.  
 To address the aims of the review, one reviewer (AOR) extracted data on the 
methodological details of studies from the 6 papers reviewed (Table 1). A second 
reviewer (MH) extracted QOL empirical findings of studies (Table 2).  Both tables 
were then checked against the papers by ES. As shown on Table 1, data extracted on 
methodological details of studies related to: study aims; sampling (e.g. participants, 
age groups of children, treatment status); study design; data collection procedures; 
data analysis; QOL measures; reliability and validity; and QOL dimensions measured.  
The quality of each quantitative study was rated drawing on criteria previously 
used by Tsimicalis et al. (2005) which addressed five study parameters. As shown in 
Table 3, these criteria related to study design, participants and recruitment, 
comparison group, number of participants, and quality of QOL instruments. Each 
parameter was scored between 0 and 3 giving a total score range of between 0 and 15 
for each study. Criteria for assessing the quality of qualitative studies were based on 
standards proposed by Popay et al. (1998) which addressed study aims, context 
sensitivity, sampling strategy, data quality, theoretical or conceptual adequacy, and 
generalisability (Table 4).    
 
Results 
 
Methodological details of studies  
Six studies met the inclusion criteria. Methodological details of these studies are 
summarised in Table 1. Three studies used the term ‘health related QOL’ (Meeske et 
al., 2004; Shankar et al., 2005; Waters et al., 2003) and 3 studies used the term QOL 
(Earle and Eiser, 2007; Hicks et al., 2003; Vance et al., 2001). For simplicity, the term 
QOL is used herein.        
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Four studies used a quantitative approach with a cross sectional design 
(Meeske et al., 2004; Shankar et al., 2005; Vance et al., 2001; Waters et al., 2003). 
Two studies were qualitative in approach including a descriptive longitudinal design 
(Earle and Eiser, 2007) and a phenomenological design (Hicks et al., 2003). Parents 
only were sampled in 2 studies (Earle and Eiser, 2007; Meeske et al., 2004) and with 
clinicians in 1 study (Waters et al., 2003). In 2 studies, children were sampled without 
their parents (Hicks et al., 2003; Shankar et al., 2005). Both children and parents were 
sampled in 1 study (Vance et al., 2001).  
 In terms of cancer groups sampled, 4 studies included only children with ALL  
(Earle and Eiser, 2007; Hicks et al., 2003; Vance et al., 2001; Waters et al., 2003) and 
2 of these assessed QOL in children on and off treatment (Hicks et al., 2003; Vance et 
al., 2001). QOL was addressed in a cross-section of childhood cancers in 1 study 
which also included an age matched healthy control group (Shankar et al., 2005). One 
study used age matched healthy population data as a reference for comparison 
(Waters et al., 2003). One study examined QOL in children with brain tumours in 
addition to ALL (Meeske et al., 2004). Convenience sampling was used in the 4 
quantitative studies and in 1 qualitative study (Hicks et al., 2003). Earle and Eiser 
(2007) used purposive sampling in their qualitative study. Sample sizes specific to 
children aged 12 years and younger receiving treatment for ALL ranged from less 
than 13 to 46 child respondents (Hicks et al., 2003; Shankar et al., 2005) and from 20 
to 144 parent respondents (Meeske et al., 2004; Waters et al., 2003).  
Interviews were the method of data collection in both qualitative studies. QOL 
measures differed across the 4 quantitative studies reviewed. A cancer specific 
measure (Minneapolis-Manchester Quality of Life Youth Form) was used by Shankar 
et al. (2005). In another study, a generic Child Health Questionnaire was used, 
complemented with a cancer specific measure (the Pediatric Cancer QL-32 Inventory) 
(Waters et al., 2003). The Pediatric Cancer QL-32 Inventory was also used by Vance 
et al. (2001). In addition, Vance et al. used a computer based measure Disquol which 
by description seemed generic. The PedsQLTM4.0 measurement model incorporating 
generic and cancer specific parent proxy scales was used by Meeske et al. (2004). The 
PedsQL TM4.0 measurement model is the result of over 15 years of programmatic 
measurement instrument development by researchers (Varni et al. 2002), and 
incorporates the Pediatric QL-32 inventory used by earlier researchers (Vance et al., 
2001; Waters et al. 2003).    
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 Dimensions of QOL assessed across most studies related to physical and 
psychological functioning or wellbeing.  All 4 quantitative studies assessed disease 
related symptoms. One study assessed emotional functioning in addition to 
psychological functioning (Meeske et al., 2004) and another study assessed 
psychosocial health in addition to psychological health (Waters et al., 2003). Social 
functioning or wellbeing was assessed in 3 studies (Hicks et al., 2003; Meeske et al., 
2004; Vance et al., 2001); cognitive functioning was assessed in 2 studies (Vance et 
al., 2001; Waters et al., 2003), and school functioning was assessed in 1 study 
(Meeske et al., 2004). Other aspects of QOL assessed were ‘outlook in life/family 
dynamics’ (Shankar et al., 2005). One study addressed QOL in the context of 
children’s behaviours over the course of treatment for ALL (Earle and Eiser, 2007).  
 
 
 
 
Quality of studies  
A total quality score ranging from 0 to 15 was allocated to each quantitative study 
based on a number of criteria specific to study design, participants and recruitment, 
comparison group, number of participants (on treatment for ALL), and QOL 
instruments (Table 5). Each parameter was allocated a score of between 0 and 3 
reflecting lower to higher level of quality. The cross-sectional design yielded a low 
score of 1 in all 4 studies. Detailed accounts of participants and recruitment processes 
were provided in all 4 studies and so each study was allocated a maximum score of 3.  
Only 1 study was allocated a maximum score of 3 for having an age matched healthy 
control group (Shankar et al., 2005). A score of 2 was allocated to 1 study for 
including age matched healthy population data as a reference group (Waters et al., 
2003). Two studies were allocated a low score of 1 for each having a comparison 
group: children with brain tumours (Meeske et al., 2004); and children off treatment 
for ALL (Vance et al., 2001). A low score of 1 was allocated to 3 studies because of 
small sample sizes of children and/or parents specific to ‘on treatment’ phase of ALL 
(Shankar et al., 2005; Vance et al., 2001; Waters et al., 2003). Meeske et al. (2004) 
was the only study with a sample size (parents) over 100 specific to children ‘on 
treatment’ and so was allocated a maximum score of 3.   
 For psychometric properties, studies by Meeske et al. (2004) and Shankar et 
al. (2005) were both allocated a high score of 3. Both studies demonstrated strong 
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psychometric properties in terms of internal consistency, reliability, and construct 
validity.  A lower score of 2 was allocated to studies that reported some weak 
psychometric properties for the QOL measures used (Vance et al., 2001; Waters et al., 
2003). For example, the Child Health Questionnaire used by Waters et al. (2003), 
although reported as having ‘generally good’ psychometric indices, had internal 
consistency values of 0.4 or lower for some items in the multi-item scale.  
 For the qualitative studies, a narrative summary of their quality based on 
standards proposed by Popay et al. (1998) is presented in Table 4.  The longitudinal 
design in 1 study was a strength in terms of context sensitivity such that changes in 
children’s QOL could be gleaned over time (Earle and Eiser, 2007). This study also 
went some way to meeting standards of ‘theoretical and conceptual adequacy’ and 
‘potential for assessing typicality’. A strength of Hicks et al.’s (2003) study was that 
perspectives on QOL were gleaned from children whereas Earle and Eiser (2007) 
relied on proxy accounts of parents, which they acknowledged as a limitation of the 
study. 
 
QOL in children on treatment for ALL – children’s and parents’ reports   
A summary of empirical findings on QOL in children on treatment for ALL are 
presented in Table 2. In presenting a narrative account of results, the findings are 
grouped into dimensions or aspects of children’s QOL addressed across studies.
 QOL in relation to physical functioning or health was poorer for children on 
treatment for ALL compared to age matched healthy controls or population data as 
reported by children (Shankar et al., 2005) and parents (Waters et al., 2003). Children 
on treatment were reported by parents as having better QOL than children off 
treatment for less than 12 months and as having poorer QOL compared to children off 
treatment for more than 12 months (Meeske et al., 2004). Areas measured for physical 
functioning were reported in 2 quantitative studies, and these related to energy levels 
and abilities to engage in physical activities including sports (Shankar et al., 2005; 
Waters et al., 2003). Qualitative data identified tiredness and depleted energy levels as 
notable adverse effects of treatment, limiting children’s abilities to be physically 
active (Hicks et al., 2003). Parents reported their children’s QOL as poorer than what 
children reported on themselves, and physical functioning was rated by parents as the 
poorest aspect of children’s QOL compared to other dimensions (Vance et al., 2001). 
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 Although 3 studies reported on psychological functioning subscales (Shankar 
et al., 2005; Vance et al., 2001; Waters et al., 2003), only 2 reported on psychological 
functioning in children aged 12 years and less and ‘on’ treatment for ALL. Children 
were reported as scoring better psychological functioning than healthy controls 
(Shankar et al., 2005) and in comparison to parents’ reports, they scored poorer 
functioning (Vance et al., 2001). Shankar et al. (2005) itemised measures of 
psychological functioning as worrying about health, dying, and ‘things in general’. 
Fears and negative feelings such as sadness, loneliness, and anger were indicative of 
psychological functioning. When children’s views were explored through interviews, 
fears were found to be associated with medication and treatment effects. Hair loss as a 
side effect to treatment was reported by some children as distressing (Hicks et al., 
2003). Parents’ accounts of children’s behavioural responses to treatment indicated 
mood changes with some children described as becoming ‘clingy’, angry or quieter, 
and withdrawn. Sleep problems and nightmares in children were also described by 
parents (Earle and Eiser, 2007). 
 Findings on psychosocial functioning or health were presented in 2 studies 
(Meeske et al., 2004; Waters et al., 2003) but data on children aged 12 years and less 
and on treatment for ALL could be extracted from 1 study only (Meeske et al., 2004). 
In this study, data on psychosocial functioning were presented as a composite score 
on emotional, social, and school functioning of children. Children on treatment for 
ALL were reported by parents as having poorer health than their counterparts off 
treatment for less than 12 months. In contrast, children on treatment were reported by 
parents as having better psychosocial health than children off treatment for more than 
12 months. Social functioning was a distinct measure in 1 study (Vance et al., 2001) 
and was reported by children on treatment for ALL as the poorest aspect of QOL 
when compared with other dimensions measured. Parents differed in their reports by 
rating children’s social functioning as marginally better than what children reported 
(Vance et al., 2001).  Both qualitative studies highlighted problems for children in 
relation to social interactions with peers, and concerns about appearing different (e.g. 
hair loss) were particularly notable (Earle and Eiser, 2007; Hicks et al., 2003).  
 Cognitive functioning was measured by Waters et al. (2003) and Vance et al. 
(2001), although only 1 of these studies reported on children aged 12 years and less. 
Vance et al. found that compared to proxy accounts of parents, children scored better 
on cognitive functioning. Indicative detail on cognitive functioning was not provided. 
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Outlook in life/family dynamics was measured as a dimension of QOL by Shankar et 
al. (2005) who found children on treatment for ALL reporting poorer QOL compared 
to age matched healthy controls. Indicators that measured children’s ‘outlook in life’ 
related to their sense of happiness with their health and life including expectations for 
the future. Family dynamics were concerned with whether parents treated children 
with ALL the same as siblings and also the levels of patience exercised by parents 
with their children.         
 When disease and treatment symptoms were assessed, children on treatment 
for ALL reported poorer QOL compared to children off treatment (Meeske et al., 
2004). In another study, children on treatment reported poorer QOL compared to 
parents’ reports (Vance et al., 2001). One study reported marginally better QOL in 
children on treatment for ALL compared to age matched healthy controls (Shankar et 
al., 2005). Although 2 studies indicated what symptoms were measured (e.g. pain and 
nausea), only 1 study provided QOL scores for each symptom and these could not be 
extracted for children aged 12 years and less (Meeske et al., 2004).  Meeske et al. 
specifically measured fatigue which was reported as problematic for children on 
treatment for ALL compared to children off treatment. However, compared to 
children on treatment for brain tumours, children reported better QOL on the Fatigue 
scale.  
 
Discussion 
This review adds to a previous review (Pickard et al., 2004) by providing an update 
on methodological aspects of studies conducted over a 6 year period (2001-2007). In 
addition, our review provides empirical findings on children’s QOL and draws 
attention to differences between parent-proxy reports and children’s self-reports on 
QOL. Unlike Pickard et al. who reviewed studies across a broad range of ages and 
treatment phases including survivors, our review specifically focused on children 
aged 12 years and less, who were undergoing treatment for ALL. Prior to this review, 
there has been no systematic examination of empirical data on QOL in children 
undergoing treatment for ALL.  
 In the past, the small number of studies conducted on QOL in children on 
treatment for ALL mostly relied on generic measures which may not be responsive to 
clinical changes during treatment stages of disease (Pickard et al., 2004). Our review 
has shown a shift towards using disease specific measures as evident in all 4 
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quantitative studies summarised in Table 1. A challenge facing researchers is the 
availability of reliable and valid measures, and shortfalls in meeting these criteria 
have limited the quality of much QOL studies in the past (Eiser and Jenney, 2007; 
Eiser and Morse, 2001). Disease specific measures reported as having sound 
psychometric properties in this review were the PedsQL TM4.0 measurement model 
which included an acute cancer module (Meeske et al., 2004), the Mineapolis-
Manchester Quality of Life Youth Form (MMQL-YF)  (Shankar et al., 2005), and the 
Pediatric Cancer Quality of Life-32 Inventory  (Vance et al., 2001; Waters et al., 
2004). Two of these measures (PedsQL, MMQL-YF) included age appropriate 
versions which are important to considering developmental changes in QOL across 
age groups (Eiser and Jenney, 2007).  
 Of the 6 studies reviewed, only 3 included children as respondents indicating 
continued reliance on parent proxy accounts by some researchers. Many children on 
treatment for ALL may be younger than 5 years making self-reports on QOL difficult 
to obtain from this age group. However, we reinforce the need to directly measure 
children’s QOL from school age years as previously recommended by Pickard et al. 
(2004). As evident in our review, children as young as 5 and 6 years demonstrated 
abilities to report on their QOL during treatment for ALL (Hicks et al., 2003; Vance 
et al., 2001).  The need to access children’s self-reports and accounts is also 
highlighted by the finding in our review that parent-proxy reports may not be 
consistent with children’s reports. As demonstrated by Vance et al. (2001), parents 
may underestimate children’s QOL in relation to their physical health. Conversely, 
they may overestimate children’s QOL in relation to their social and psychological 
health, which were the areas reported by children as the poorest of all QOL 
dimensions measured. However, in future research, there is a continued need to glean 
parents’ reports in order to better understand the relationships between child and 
parent reports on QOL therefore adding to the work of Vance et al. (2001).   
 Although data on various dimensions of children’s QOL were gleaned through 
this review, the findings are somewhat fragmented overall. Studies varied in 
dimensions of QOL studied and reported on. While most studies assessed physical, 
psychological and social aspects of QOL, only 1 study explicitly examined cognitive 
functioning (Vance et al., 2001). Data on social functioning, although examined 
across most studies, could not be extracted in all cases. For example, these data could 
not be extracted specific to children aged 12 years and under in the study by Waters et 
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al. (2003). Furthermore, some quantitative reports were noted to be limited in detail 
regarding indicators of QOL specific to each dimension, which raises questions about 
the interpretability and usefulness of QOL data to practitioners working with children 
with ALL. In contrast to measurement data, the 2 qualitative studies provided insights 
into the meanings of QOL from children’s (Hicks et al., 2003) and parents’ 
perspectives (Earle and Eiser, 2007). The contribution that qualititative data can make 
to understanding QOL experiences of children with ALL needs consideration in 
future research to complement measurement data on QOL.  
 The variations in QOL dimensions measured across studies reflect diversity in 
how QOL is conceptualised in research (Eiser and Morse, 2001; Wallander, 2001). 
Although QOL was recognised as a multidimensional construct in all studies 
reviewed, little discussion was given to the theoretical basis of this construct. Theory 
development in QOL research is considered paramount for better understanding of its 
constructs and the relations between constructs (Wallander, 2001). To date, there has 
been little effort at developing QOL theory in the area of childhood cancers compared 
to other client groups in health care such as the elderly (e.g. Register and Herman, 
2006; Hyde et al., 2003). While it is beyond the scope of this paper to engage in a 
detailed discussion on QOL theory development, recommendations for developing 
theory driven models of QOL are offered. A fundamental step towards a better 
understanding of QOL is to undertake a concept analysis to define the boundaries of 
QOL by clarifying its critical attributes. A concept analysis also involves examining a 
concept’s current usage, its antecedents (precursors) and its consequences (outcomes). 
In addition, empirical referents need to be identified to illustrate when a concept is 
present, which in turn has implications for items included in a measurement scale 
(Walker and Avant, 1995). Given the subjective nature of QOL that emphasises an 
individual’s perspective (Eiser and Morse, 2001), theory development needs to take 
account of children’s perceptions of QOL. To this end, qualitative research using 
grounded theory methodology (Glaser and Strauss, 1967) has potential. Empirical 
validation or testing of developing theory is vital to revising and building a 
theoretically driven model of QOL (Walker and Avant, 1995).  
 In moving forward with a theoretically driven model of QOL and its 
measurement, future research needs to address limitations identified in this review in 
terms of design and sample sizes. We reinforce previous recommendations made by 
Pickard et al. (2004) that called for longitudinal research designs and larger sample 
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sizes in QOL studies in children. European and international collaboration between 
researchers may be necessary to recruit large samples of children on treatment for 
ALL. The feasibility of undertaking European and international QOL studies in terms 
of recruiting large sample sizes across a number of countries despite differences in 
languages has been demonstrated for populations other than childhood cancer groups 
(Hardt et al., 2001; White-Koning et al., 2007).     
 
Conclusions  
 
This review reports on QOL research on children with ALL drawing on quantitative 
and qualitative studies conducted between 2001-2007.  Efforts at advancing the study 
of QOL in children on treatment for ALL were noted, as evident in a longitudinal 
study design in 1 study, qualitative research in 2 studies, direct access to children’s 
reports on QOL in 3 studies, and a shift towards using disease specific QOL 
measures. The studies illustrate the potential to continue advancing the methodology 
of QOL research on children with ALL.  The knowledge gleaned from future 
research, especially empirical data, could provide useful information for practitioners 
when addressing QOL care with children on treatment for ALL. Although this review 
is based on a small number of studies, it provides a basis for updating over time as 
new studies are published.  
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Table 1 Methodological details of studies 
Authors, 
year, 
country 
Aim of Study Sample Details 
specific to 
ALL 
Design, data collection and analysis Details of QOL measures (if 
applicable) and of reliability and 
validity  
 Quality of life 
dimensions 
Earle & 
Eiser 
(2007), 
U.K. 
 
 
 
 
 
 
 
 
Shankar,  
et al. 
(2005), 
USA 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
To examine how 
children of 
different age 
groups respond 
over time to 
treatment for ALL 
from the time of 
diagnosis 
 
 
 
 
To assess the 
health related 
quality of life 
(HRQOL) of 
children 
undergoing therapy 
for cancer and 
childhood cancer 
survivors 
 
 
 
 
 
 
 
 
 
 
32 Mothers of 
children  
0-14 yrs 
Age groups 
<12yrs:  
0-4yrs (n=14)    
5-9yrs (n=11) 
10-14 yrs (n=7) 
 
 
 
 
Convenience 
sample of children  
8-12 yrs with 
cancer on (n=72) 
and off (n=90)  
therapy    
Cancers: 
leukaemia, 
lymphoma, brain 
tumour & other 
solid tumours   
 
Age matched 
healthy controls 
(n=481) 
 
 
 
 
ALL n=32 
(100%) 
 
All children 
receiving 
treatment for 
ALL over a 
2-3 year 
period 
 
 
46 (64%) 
children 
with ALL on  
therapy for 
at least 2 
months; 44 
(49%) 
children had 
completed 
therapy and 
were in 
remission 
for ≥ 12 
months.  
 
 
 
 
 
 
Design: Qualitative, descriptive, 
longitudinal, prospective design 
Data collection: 
Three semi structured interview schedules 
administered over three time periods 
Time 1: 3-4 months following diagnosis 
Time 2: 1 year later at 15 months  
Time 3: 2 years later at 27 months 
Data analysis: 
Thematic content analysis 
 
 
Design: Quantitative cross-sectional 
survey; multicentre 
Data collection: Standardized self report 
measure administered by interview at 
clinics;  Minneapolis-Manchester Quality 
of Life Youth Form (MMQL –YF); 
Measurement questionnaire was 
administered to control group by 
telephone interview  
Data analysis:  
Analysis of variance techniques used to 
compare means between groups; Multi-
regression analysis to investigate 
predictors of poor HRQOL (diagnosis, 
age, time since diagnosis, gender & 
ethnicity); Statistical significance set at 
.05; Multivariate models constructed to 
calculate relative risk estimates for poor 
HRQOL  
Qualitative study and so no 
standardised measure used  
Reliability and validity: Fifty 
percent of interviews were coded 
independently by a second 
researcher to check for interrater 
reliability; Interview schedule 
remained the same at each time 
point for comparability and 
reduction of bias; Discrepancies 
were resolved by discussion  
 
MMQL - YF - Designed for use 
with survivors of childhood cancer 
but may be used to assess HRQOL 
of patients on and off cancer 
treatment and of healthy controls 
(4 scale measures with total of 32 
items; Scores range from 1-5 (5 = 
maximum HRQOL); Overall 
HRQOL score also measured 
Reliability and validity: 
Previously published (Bhatia et al 
2004) as demonstrating internal 
consistency reliability (x =.85); 
ability to distinguish between 
known groups, construct validity 
with scales correlating highly with 
CHQ dimensions; Test/retest 
demonstrated stability in all scales    
 
Behavioural 
responses to 
diagnosis, 
treatment 
symptoms and 
affects on normal 
life 
 
 
 
 
 
Physical 
symptoms, 
Physical 
functioning, 
Psychological 
functioning, 
Outlook on life/ 
family dynamics 
 
 
 
 
 
 
 
 
 
 
 
Meeske 
et al. 
(2004), 
USA 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
To evaluate and 
compare HRQOL 
in children with 
brain tumours (BT) 
and ALL 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Convenience 
sample of 256 
parents of children 
aged 2-18 yrs with 
BT and ALL   
60% (n=153)  of 
children were on 
treatment   
Age groups  <12 
years:  
2-4yrs (n=53)  
5-7yrs (n=72)  
8-12yrs (n=83) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
170 (66%) 
children 
with ALL 
and of these 
144 were on 
treatment for 
age groups 
<12yrs.  
 
 
 
Age Groups 
of ALL -  
 
2-4yrs 
(n=42);  
5-7yrs 
(n=51);  
8-12yrs 
(n=51) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Design: Quantitative cross- sectional 
survey 
Data collection:  
Standardised parent proxy reports using 
PedsQL™ 4.0 Measurement Model 
comprising (i) PedsQL™ 4.0 Generic 
core scales; (ii)PedsQL™ 3.0 Acute 
cancer module; (iii) PedsQL™ 
Multidimensional fatigue scales; (iv) 
PedQL™ Family Information Form for 
demographic data  
All measures administered in clinics 
Medical chart data extracted from notes  
Data analysis: 
Descriptive statistics (means, standard 
deviation, frequencies) for all variables;   
Inferential statistical analyses (analysis of 
variance, regression analysis, chi squared 
tests, t-tests, Pearson correlation) were 
conducted as appropriate to making group 
comparisons and correlations between 
variables including demographic data  
 
 
 
 
 
 
 
 
 
 
 
 
 
PedsQL™ Measurement Model 
consisting of 4 age appropriate 
versions designed to evaluate the 
HRQOL of children 
(i) PedsQL™ 4.0 Generic core 
scale – parent proxy report, a 23 
item scale consisting of a 5 point 
likert scale to determine how 
problematic a particular item has 
been for the individual child; 
reference period is past 7days; 
higher scores indicate greater 
HRQOL. 
(ii) PedsQL™ 3.0 Acute cancer 
module –parent proxy report with  
dimensions specific to cancer; each 
dimension is scored and a total 
scale score is also calculated 
(iii) PedsQL™ Multidimensional 
fatigue scales-parent proxy report 
consisting of 18 items divided into 
3 subscales; subscales are scored 
and a total scale score is also 
calculated 
 Reliability and validity: 
Previously published (Varni et al, 
2002) as demonstrating strong 
internal consistency reliability for 
each measure, ability to distinguish 
between known groups, construct 
validity for interrelationships 
between measures; For this study, 
a Cronbach’s  alpha coefficient 
value of >0.70 was achieved for 
both the PedsQL™ 3.0 Acute 
Physical health.  
psychological, 
emotional, social 
and school 
functioning  
 
Cancer related 
physical 
symptoms, 
psychological 
concerns, and 
cognitive 
problems 
 
Fatigue (general, 
rest/sleep, 
cognitive 
fatigue)    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Hicks et 
al, 
(2003), 
USA 
 
 
 
 
 
 
 
 
 
 
Waters et 
al. 
(2003), 
Australia 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
To allow children 
with leukaemia 
describe their QOL 
experiences  
 
 
 
 
 
 
 
 
 
 
To compare 
parents’ and 
clinicians’ reports 
on HRQOL in 
children with 
leukaemia  
Age matched 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Convenience 
sample of 13 
children aged  
5 -9 yrs 
 
 
 
 
 
 
 
 
 
 
Convenience 
sample of 31 
parents of children 
aged 5 -18 years  
Most parents 
(n=25) were 
mothers  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
All children 
had ALL 
and had 
either 
completed at 
least 6 
months 
treatment or 
were off  
treatment.  
 
 
 
 
All children 
had ALL 
and were on 
maintenance 
phase of 
treatment 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Design: Qualitative phenomenological 
Data collection: 
Audiotape interviews by focus groups 
were held to coincide with treatment 
schedules; four semi structured questions 
guided the interviews; the interview room 
had a two way mirror to allow researchers 
visual access to data collection process   
Data analysis:  
Content analysis to identify significant 
statements using first 4 steps of Colazzi’s 
phenomenological technique aided by 
HyperResearch computer package  
 
Design: Quantitative cross- sectional 
survey 
Data collection:  
Standardized parent report questionnaires:  
child health questionnaire  (CHQ) and 
Pediatric cancer quality of life inventory 
(PCQL-32); questionnaire to collect 
cancer module and the PedsQL™ 
Multidimensional fatigue scale 
which is recommended for group 
comparisons; A moderate 
correlation (r = 0.75-0.79) between 
the PedsQL™ 4.0 Generic Core 
total score and the total scores on 
the PedsQL™ 3.0 Acute cancer 
module and the PedsQL™ 
Multidimensional fatigue scale 
suggesting that HRQOL and 
fatigue are highly related although 
unique.     
 
Qualitative study so no 
standardised measure used  
Reliability and validity: 
Verbatim transcription of 
interviews; transcripts checked 
against audiotapes by one 
researcher to ensure accuracy; 
significant statements extracted 
from the data were analysed by 
three researchers  
 
 
 
 
Child Health Questionnaire (CHQ) 
is a 50 item measure with 13 single 
and multi item scales of child 
health and 2 summary scores 
(physical and psychological 
health); scores for CHQ range 
from 0 to 100 i.e. worse to better 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Conceptual 
framework of 
QOL 
dimensions: 
physical 
wellbeing and 
symptoms; 
psychological 
wellbeing; social 
wellbeing; 
spiritual 
wellbeing   
 
 
Physical health,  
psychosocial 
health. 
Cognitive 
functioning,  
Psychological 
functioning,  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Vance et 
al. 
(2001), 
U.K. 
 
 
healthy population 
data (Australian) 
used for 
comparison  
 
 
Note: Data specific 
to parents only 
reported in this 
table  
 
 
 
 
 
 
 
 
 
 
 
 
To explore the 
relationship 
between child self 
report and parent-
proxy report on 
QOL and the 
effects of parental 
mental health, 
illness stressors, 
and child 
vulnerability 
Age groups <12 
yrs were 5-11 yrs 
(n=20) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Convenience 
sample of:  
36 parents of 
children aged 6-12 
yrs with ALL &  
32 children (6-12 
yrs)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
All children 
had ALL 
36% (n=13) 
were on 
“active 
treatment” 
Remaining 
children 
were follow 
ups  
sociodemographic information; data 
collected in out patient clinic 
Data analysis:  
Comparison with normative Australian 
sample previously collected; effect sizes 
were used to demonstrate the size of 
difference; independent t-tests were used 
to determine significance levels; 
Pearson’s correlation test was used to 
calculate relationships between 
continuous scale sores of the CHQ and 
the PCQL; family characteristics were 
compared across normative and ALL 
samples 
 
 
 
 
 
 
 
 
Design: Quantitative cross sectional 
survey 
Data collection  
Parent completed self administered 
measures – the Pediatric Cancer Quality 
of Life-32 (PCQL32) parent form,; Child 
Vulnerability Scale (CVS); General 
Health Questionnaire (GHQ-28); Illness 
stressors scale 
 All 3 measures were completed during a 
clinic visit.  
All children completed the Disquol 
measure  
health; CHQ is based on 4 week 
recall except ‘change in health’ 
item which is based on previous 12 
months 
3 scales from PCQL -32; items that 
overlapped with CHQ were 
omitted; items were based on a one 
month recall; higher scores 
indicated poorer health status  
Reliability and validity: CHQ 
reported to have “good reliability 
and validity” based on previous 
population and clinical (incl. 
oncology) studies, although 
psychometric indices of items in 
some scales were weak (0.4 or 
less);  PCQL-32 reported to have 
previously demonstrated internal 
consistency reliability (0.92), 
clinical and construct validity 
(Varni et al. 1998)  
 
 PCQL-32: a 32 item questionnaire 
with 5 Likert subscales organised 
around 5 dimensions of QOL; 
ratings are based on previous 
month on a 4 point Likert scale 
ranging from ‘never a problem’ to 
‘always a problem’ and scored 0-3; 
includes a child and parent form   
Disquol: a 12 item computer- 
measure focusing on picture 
situations relevant to children 6-12 
yrs aimed at measuring ‘actual-
ideal self-discrepancy’; in a visual 
Disease and 
treatment related 
symptoms 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Physical, 
psychological, 
social and 
cognitive  
functioning;  
disease and 
treatment related 
symptoms. 
 
 
 
 
 
In addition, children aged 8-12 completed 
the child form PCQL-32 measure  
Researchers worked with children to 
complete measures in a separate room to 
parents 
Data analysis: 
Descriptive statistics (means, standard 
deviations, ranges) were calculated for all 
measures; inferential statistics (partial 
correlations, multivariate analysis, t tests) 
were used to determine concordance 
between QOL measures and parent and 
child reports with PCQL-32; scores were 
computed with reference to demographic 
variables; correlation tests were applied to 
determine relationships between parental 
mental health, perception of child’s 
vulnerability, perceived illness stressors, 
and parent and child QOL ratings   
analogue scale, children identify 
how much the picture situation is 
‘not like me/don’t want to be like 
that” to ‘exactly like me/really 
want to be like that’ ranging in 
score from 0 to 100  
Reliability and validity: 
Disqol :internal reliability was 
reported as moderate (>.64) based 
on previous research and 
preliminary analyses for this study 
showed moderate internal 
consistency for the discrepancy 
score (.55); evidence of criterion 
validity and discriminant validity 
(chronic illness v healthy control) 
were noted as achieved from 
previous research   
PCQL-32: strong internal 
consistency reported for child (.86) 
and parent (.93) measures; reported 
to have demonstrated clinical and 
construct validity; external internal 
consistency previously reported for 
child (.91) and parent (.92) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
       
 
 
 
 
 
 
 
 
 
Table 2     Summary of Empirical Findings on QOL in Children on treatment for ALL  
Authors, 
year,  
 
Context of Data  QOL Domains & Total QOL scores if stated/applicable  
 
Earle & 
Eiser., 
(2007) 
 
 
 
 
 
 
 
 
Shankar  
 et al. 
(2005) 
 
 
 
 
 
 
 
Meeske 
et al. 
(2004)  
Mothers  accounts 
of QOL in children 
with ALL (aged 0-
9 yrs)  
 
 
 
 
 
 
 
Children’s reports 
on HRQOL, aged 
8-12 yrs, on 
therapy for ALL 
compared to 
children off 
therapy for ALL, 
on/off therapy for 
other cancers & 
age matched 
healthy controls 
group  
Responses to Treatment: Younger children (0-4yrs) described as ‘moody, ‘clingy’ tired and these 
problems continued over time. Problems reported for older children (5-9yrs) included being: ‘moody’, 
‘clingy’ and ‘aggressive’; quieter and passive in behaviour since diagnosis; sleep problems and 
nightmares. At 15 months following diagnosis, more positive behaviours and better adjustment to illness 
experience were reported, although treatment procedures were reported as distressing for some children.    
Focus on Normal Life overall: In the early months following diagnosis, few social problems reported for 
younger children (0-4yrs) compared to older children (5-9yrs) who had problems mixing socially with 
peers. At 15 months following diagnosis, some younger school aged children were settling into school 
whereas others were reported to have problems associated with changes in appearances. Most older 
children were reported to be self-conscious and reluctant to go to school. Bullying was a concern.  At 27 
months following diagnosis, socialising at school and bullying was more problematic for younger 
children. Some older children were now interacting well with peers whereas others were still having 
problems.   
 
Physical Functioning:   Significantly lower (poorer) HRQOL mean score in children with ALL (3.5) 
compared to healthy controls (4.0) (P <001), and lower than one other cancer group (solid tumours). 
Psychological Functioning:   Marginally higher HRQOL mean score in children with ALL (3.95) 
compared to health controls (3.83) (P = .17)); rated 2nd lowest mean score across all cancer groups. 
Outlook in Life:  Significantly lower mean score in children with ALL (3.9) compared to healthy controls 
(4.2) (P< .001); rated 2nd highest mean score across all cancer groups. Physical Symptoms:  Marginally 
higher HRQOL score in children with ALL (4.21) compared to healthy controls (4.17) (P = .37); rated 2nd 
lowest mean score across all cancer groups. Total QOL Score: Significantly lower (poorer) in children on 
therapy compared to healthy controls  (3.93 v 4.05; P =.01) using the MMQL-YF scale with a sore of 5 
indicating maximum HRQQL.  Total HRQOL mean score was higher for ALL compared to children with 
 
 
 
 
 
 
 
 
 
 
 
 
 
Hicks et 
al. 
(2003) 
 
 
 
 
 
 
 
Waters 
et al. 
(2003)  
 
 
 
 
Parent reports on 
children’s 
HRQOL,  extracted 
for those aged  2-
12 yrs  
on treatment for 
ALL compared to 
children off 
treatment for ALL, 
and to children 
with  on/off 
treatment for brain 
tumour 
 
 
 
 
 
 
Children’s 
accounts of QOL, 
aged 5-9 yrs, on 
treatment for ALL 
 
 
 
 
 
brain tumours and lymphoma but lower than for children on treatment for solid tumours.     
 
Physical Health:   Children on treatment for ALL were reported as having a higher (better HRQOL) mean 
score (71.0) compared to children off treatment for <12 months (65.4) and a lower mean score than 
children off treatment for > 12months (77.9) (p = 0.03). Children on treatment for ALL were reported as 
having a higher HRQOL mean score compared to children on treatment for BT.  Psychosocial Health ( 
summary score for emotional, social and school functioning):  Marginally poorer HRQOL mean score 
(70.4) reported for children on treatment for ALL compared to children off treatment for <12 months 
(74.5)and off treatment for > 12 months  (72.4) (P = 0.21).  Children on treatment for ALL were reported 
as having higher HRQOL mean scores than children on treatment for BT (70.4 v 64.8). Cancer specific 
problems:  Children on treatment for ALL had a lower (poorer HRQOL) score (73.4) compared to 
children off treatment for <12 months (79.5) and compared to children off treatment for > 12months 
(78.5) (P = 0.008). Children on treatment for ALL were reported as having better HRQOL than children 
on treatment for BT (68.5). Fatigue:   Children on treatment for ALL were reported as having a lower 
(poorer HRQOL) mean score (74.6) compared to children off treatment for <12 months (76.8) and 
compared to children off treatment for > 12months (80.2) indicating more fatigue symptoms during 
treatment (P = 0.009). Children on treatment for ALL were reported as having better HRQOL scores 
compared to children on treatment for BT (74.6 v 64.9). Total HRQOL: Apart from the Acute Cancer 
Worry Subscale, children with ALL were reported as having better HRQOL than children with BT.  
 
Physical Wellbeing: Limited ability to engage in physical activities (e.g. football, soccer, climbing trees, 
cycling) due to tiredness. Engaged in passive activities because of limited abilities to be physically active. 
The theme of tiredness was the most notable theme expressed in the data.  Psychological Wellbeing: Fear 
associated with medication and treatment effects when in hospital. Hair loss was described by 1 
participant as distressing although it was mentioned in general by 10 participants.  Social Wellbeing:  
Changes in friendships arising out appearing different due to hair loss. Social interactions with peers 
limited due to tiredness. Changes in family relationships associated with parental worrying about child.  
 
 
 
 
 
Vance 
 et al.  
( 2001) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Parent reports on  
children’s  
HRQOL,     
extracted for those 
aged 5-12 yrs , 
Australian age 
matched healthy 
population data 
used for 
comparison   
 
Parent and child 
reports on QOL, 
aged 6-12 yrs, on 
/off  treatment  
 
 (Data were 
controlled for 
treatment status)  
Physical Health:  Children with ALL were reported as having significantly poorer HRQOL than aged 
matched population sample. The largest effect sizes (>1 SD below the population mean) were noted on 
Physical Functioning, Role Physical, and General Health scales. A mean difference score of >5 lower was 
noted across these scales and was reported as clinically important.  
 (Findings on measurements  of HRQOL  were presented for all children aged 5 to 18 years and so data 
specific to those aged 12 years and less could not be extracted).  
 
 
PCQL-32 SCALES 
Physical Functioning: Children’s mean rating was lower (0.60) than that of parents (1.19) indicating 
poorer QOL perceived by parents (t = 3.05, p< .01). Poorest agreement between children and parents was 
found for this domain (r=.06) (and with ‘disease and treatment aspects summarised below). Of all 
domains, parents’ mean rating was highest for this domain suggesting that they perceived children’s QOL 
to be poorest in relation to physical functioning.   Psychological Functioning: Children’s mean rating 
was lower (0.76) than that of parents (0.81) indicating poorer QOL perceived by parents (t =0 .57, p< .05). 
Although parents and children differed, they were closer in agreement (r = .15) for this domain compared 
to ‘physical functioning’(r=.06) and ‘disease and treatment aspects’ (r=.01). The mean rating of parents’ 
reports was lowest for this domain (and social domain) suggesting that they perceived children’s QOL to 
be highest in relation to psychological and social functioning.   Social Functioning: The mean rating of 
children’s reports was marginally higher(0.89) than that of parents (0.81) indicating slightly better  QOL 
perceived by parents (t = -0.42, p< .05). Of all domains, children’s mean rating was highest (ie poorest) 
for this domain suggesting that children perceived their QOL to be poorest in relation to social 
functioning. Moderate agreement between parent and child reporting for this domain (r =.40,p<.05). 
Cognitive Functioning: Children’s mean rating was lower (0.63) than that of parents (0.97) indicating 
poorer QOL reported by parents (t = 2.83, p< .01).  Moderate agreement between parent and child 
reporting for this domain (r =.44,p<.05). Disease & Treatment Aspects: Children’s mean rating was lower 
(0.58) than that of parents (0.92) indicating poorer QOL perceived by parents (t = -2.25, p< .05). Poorest 
agreement between children and parents was found for this domain (r=.01) (and with ‘physical 
functioning summarised above). Poorer disease and medical functioning was reported by parents of 
children on treatment compared to parents of children off treatment (t(32) =2.37,0<.05). Total QOL:  
Mean rating for children’s reports was 0.70 compared to 0.94 for parents’ reports indicating poorer overall 
QOL perceived by parents.    
Discrepancies between Children and Parents: As noted for the above domains, there was poorer 
agreement for physical functioning and disease and treatment aspects of QOL compared to psychological 
functioning, and in addition for total QOL ratings (r = .21). Moderate agreement was found between 
parent and child reports on social functioning and cognitive functioning. Mean differences between 
parental and child reports on the PCQL-32 scale were not related to age, gender or treatment status.   
DISQUOL:  Older children reported better ‘actual self’ scores compared to younger children (r = .46, 
p<.01) and smaller discrepancy scores (r = -.38, p<.05). When DISQUOL measures were correlated with 
PCQL scales, levels of agreement were: good between ‘actual self’ and social functioning (-.71, p<.01); 
and overall QOL score (-.63, p< .05) QOL (PCQL-32);  moderate between ‘actual self’ and physical  
functioning (-.48, p<.05), ‘actual self’ and  psychological functioning (-.37) and ‘actual self’ and ‘disease 
and treatment aspects’ (-.41); poor between ‘actual self’ and cognitive functioning (..11).  For the ‘ideal’ 
self’, level of agreement ranged from poor to good. Poorest agreement was found with cognitive (.18) and 
social (-.29) functioning. The highest level  of agreement was with physical functioning (-.58, p<.05).   
     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3  Criteria for rating methodological quality of quantitative studies 
 Study parameter Rating Criteria 
1. Study design  
 
 
3 
2 
1 
0 
Longitudinal prospective design (explicitly stated) 
Retrospective or mixed design (explicitly stated) 
Cross-sectional (explicitly stated) 
Survey or did not report 
 
2. Participants and 
recruitment  
 
 
 
 
 
3 
 
 
2 
1 
0 
Description of the population (1), and eligibility criteria 
for participants (2), precise details of the recruitment 
process (3), accounted for the numbers recruited (4), and 
lost to follow-up (5)  
Minimal description of at least four criteria 
Two criteria missing 
More than two criteria missing 
 
3. Comparison group 
 
 
 
 
 
3 
2 
1 
 
0 
 
Healthy, age-appropriate comparison 
Reference sample 
Other comparison group (i.e. Adult BMT group, parent-
report) 
No comparison group 
 
4. Number of 
participants (specific 
on treatment for ALL)  
 
 
3 
2 
1 
0 
 
N>100 
N=50–100 
N<50 
Did not report 
 
5. QOL Instruments* 
 
 
 
 
3 
 
2 
 
Psychometrically sound report of generic and/or 
disease-specific QOL measures. 
Some weak psychometric properties reported for generic 
 
 
 
 
Source:  Tsimicalis et al. (2005).  (Permission given by Elsevier to 
re-produce Table)   
* Amended to give a higher score to use of generic and/or disease 
specific measure. Reference to child report and/or proxy report 
removed. 
 
 
 
 
 
 
Table 4. Quality criteria for assessment of qualitative research (Popay et al. 1998) 
Standards for systematic review of qualitative data 
 
Earle & Eiser, 2007 Hicks et al. 2003 
Lay accounts and subjective data as the primary marker 
    
Proxy accounts of parents   Children’s perspectives on QOL.  
Context sensitivity - flexible and responsive to changes or 
issues that may arise during the study? 
 
Longitudinal design to capture changes in 
QOL over time. Semi structured interviews 
used.  
Standardised procedure applied to data 
collection using semi-structured interviews 
conducted in clinic settings.  
Sampling strategy: - purposively chosen to generate the type 
of knowledge necessary to understand the structures, contexts 
and meanings within which individuals are located? 
 
Purposive sample across age groups and at 
different stages of treatment for ALL.  
Convenience sampling 
Data quality:  - detailed description of the meaning and 
context of data; comparisons and contrasts of different 
sources of knowledge about the same issue provided (i.e. 
constant comparative analysis); transparency of processes by 
which data have been collected, analysed and presented.  
 
Detailed description of data provided  
Thematic analysis of data.  No specific 
reference to using constant comparative 
analysis. A transparent account of research 
processes was reported. 
Detailed quotations presented.  Content 
analysis of data using Colazzi’s technique. 
No specific reference to using constant 
comparative analysis. A transparent account 
of research processes was reported.  
 
 
 
 
 
 
 
 
 
 
1 
 
0 
 
 
 
 
 
 
 
and/or disease-specific QOL measures  
Psychometric properties of instruments  reported as 
inadequate for measuring QOL  
No psychometric properties reported 
 
 
 
 
 
 
 
Theoretical or conceptual adequacy -  process of data 
analysis visible, illustrating the move from description to 
interpretation of its meaning and significance 
 
Data analysis and presentation moves from 
description to interpretation of how children 
adjusted and responded to treatment for ALL 
over time. Conceptualised as ‘coping with 
treatment’ and ‘normal life’.   
Descriptive presentation of data analysis 
with little conceptual or theoretical 
development.  
Potential for assessing typicality:  -  claims about 
generalizability of findings to either other bodies of 
knowledge or to other populations or groups?  
 
Applicable to informing professionals about 
children’s likely reactions to treatment, 
although limited by proxy accounts.  
Inability to generalize findings 
acknowledged.  
 
 
 
 
Table 5 Quality rating of quantitative studies  
Study Study parameters                                   
Total 
Study 
design 
Participants 
and recruitment 
Comparison 
group 
Number of 
participants 
QOL instrument –
psychometric property  
 
 
 
Shankar et al (2005)  1 3 3 1 3 11 
Meeske  et al. (2004)  1 3 1 3 3 11 
Waters et al.. (2003)  1 3 2 1 2  9 
Vance et al. (2001)  1 3 1 1 3  9 
 
 
 
 
 
